These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6140425)

  • 1. Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption.
    Venitt S; Crofton-Sleigh C; Hunt J; Speechley V; Briggs K
    Lancet; 1984 Jan; 1(8368):74-7. PubMed ID: 6140425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary excretion of mutagens and cisplatin among the nursing staff at a medical oncology department exposed to cytostatic drugs].
    Clonfero E; Granella M; Gori GP; Venier P; Levis AG; Morandi P; Bartolucci GB; Saia B
    Med Lav; 1989; 80(5):412-9. PubMed ID: 2622413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy.
    Nygren O; Lundgren C
    Int Arch Occup Environ Health; 1997; 70(3):209-14. PubMed ID: 9298405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies.
    Ensslin AS; Huber R; Pethran A; Römmelt H; Schierl R; Kulka U; Fruhmann G
    Int Arch Occup Environ Health; 1997; 70(3):205-8. PubMed ID: 9298404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
    Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
    Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods.
    da Costa AC; Vieira MA; Luna AS; de Campos RC
    Talanta; 2010 Oct; 82(5):1647-53. PubMed ID: 20875558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring mutagenicity in urine and peripheral blood lymphocytes of pharmacists occupationally exposed to anticancer drugs.
    Elliott G; Ferguson L; Everts R; Edwards R
    N Z Med J; 1990 Jan; 103(882):13-6. PubMed ID: 2406649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of urine from nurses handling cytotoxic drugs.
    Gibson JF; Gompertz D; Hedworth-Whitty RB
    Lancet; 1984 Jan; 1(8368):100-1. PubMed ID: 6140394
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs.
    Ensslin AS; Pethran A; Schierl R; Fruhmann G
    Int Arch Occup Environ Health; 1994; 65(5):339-42. PubMed ID: 8175190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents.
    Connor TH; Theiss JC; Anderson RW; Puckett WH; Matney TS
    Am J Hosp Pharm; 1986 May; 43(5):1236-9. PubMed ID: 3521267
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs.
    Román DA; Pizarro I; Rivera L; Torres C; Avila J; Cortés P; Gill M
    BMC Res Notes; 2012 Apr; 5():207. PubMed ID: 22546077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cytogenetic methods to determine mutagenic changes in the blood of pharmacy personnel and nurses who handle cytotoxic agents.
    Cooke J; Williams J; Morgan RJ; Cooke P; Calvert RT
    Am J Hosp Pharm; 1991 Jun; 48(6):1199-205. PubMed ID: 1858797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests.
    Labuhn K; Valanis B; Schoeny R; Loveday K; Vollmer WM
    Cancer Nurs; 1998 Apr; 21(2):79-89. PubMed ID: 9556934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations.
    Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):5-10. PubMed ID: 12592576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy].
    Leboucher G; Serratrice F; Bertholle V; Thore L; Bost M
    Bull Cancer; 2002 Nov; 89(11):949-55. PubMed ID: 12495882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
    Tuffnell PG; Gannon MT; Dong A; DeBoer G; Erlichman C
    Am J Hosp Pharm; 1986 Feb; 43(2):344-8. PubMed ID: 3513557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
    Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.
    Hopfer SM; Ziebka L; Sunderman FW; Sporn JR; Greenberg BR
    Ann Clin Lab Sci; 1989; 19(6):389-96. PubMed ID: 2690729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.